Pharsight

Paragon Bioteck patents expiration

1. Phenylephrine Hydrochloride patents expiration

PHENYLEPHRINE HYDROCHLORIDE Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8859623 PARAGON BIOTECK Methods and compositions of stable phenylephrine formulations
Nov, 2033

(10 years from now)

Drugs and Companies using PHENYLEPHRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 21 March, 2013

Treatment: Dilation of the pupil

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage

PHENYLEPHRINE HYDROCHLORIDE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic